Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Twist Bioscience Corporation before investing.

In this article, we go over a few key elements for understanding Twist Bioscience Corporation’s stock price such as:

• Twist Bioscience Corporation’s current stock price and volume
• Why Twist Bioscience Corporation’s stock price changed recently
• Upgrades and downgrades for TWST from analysts
• TWST’s stock price momentum as measured by its relative strength

About Twist Bioscience Corporation (TWST)

Before we jump into Twist Bioscience Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Want to learn more about Twist Bioscience Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Twist Bioscience Corporation.

Twist Bioscience Corporation’s Stock Price as of Market Close

As of January 16, 2026, 4:00 PM, CST, Twist Bioscience Corporation’s stock price was $41.410.

Twist Bioscience Corporation is up 0.34% from its previous closing price of $41.270.

During the last market session, Twist Bioscience Corporation’s stock traded between $40.200 and $42.600. Currently, there are approximately 60.42 million shares outstanding for Twist Bioscience Corporation.

Twist Bioscience Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Twist Bioscience Corporation Stock Price History

Twist Bioscience Corporation’s (TWST) price is currently up 30.55% so far this month.

During the month of January, Twist Bioscience Corporation’s stock price has reached a high of $42.600 and a low of $31.000.

Over the last year, Twist Bioscience Corporation has hit prices as high as $55.333 and as low as $23.300. Year to date, Twist Bioscience Corporation’s stock is up 30.55%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Twist Bioscience Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 16, 2026, there were 0 analysts who downgraded Twist Bioscience Corporation’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Twist Bioscience Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Twist Bioscience Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Twist Bioscience Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Twist Bioscience Corporation (TWST) by visiting AAII Stock Evaluator.

Relative Price Strength of Twist Bioscience Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 16, 2026, Twist Bioscience Corporation has a weighted four-quarter relative price strength of 5.72%, which translates to a Momentum Score of 70 and is considered to be Strong.

Want to learn more about how Twist Bioscience Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Twist Bioscience Corporation Stock Price: Bottom Line

As of January 16, 2026, Twist Bioscience Corporation’s stock price is $41.410, which is up 0.34% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Twist Bioscience Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.